Caribou Biosciences cariboubio.com


Public list: 2017 Game Changers (36) Game Changers 2016 (36) Synthetic Biology (137) Pharma Startups (4732) Animal Health Startups (186) Industrial SynBio (67)

Caribou Biosciences is a developer of cellular engineering and analysis solutions based on CRISPR technologies, which provide enhanced capabilities to therapeutic development, agricultural biotechnology, industrial biotechnology, and basic and applied biological research.

Caribou Biosciences is a developer of cellular engineering and analysis solutions based on CRISPR technologies, which provide enhanced capabilities to therapeutic development, agricultural biotechnology, industrial biotechnology, and basic and applie...Show all

Company (Alive / Active)

All investors data 9 Investors

Phone: 510-982-6030

Fax:

2929 7th Street
Suite 105
 Berkeley, 94710
 California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Caribou Biosciences $41.6M May 16, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Caribou Biosciences Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 9 investors

Board Members

Name Firm
Login to see detailsAnterra Capital
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Engineered nucleic acid-targeting nucleic acids Sep 14, 2017 May 15, 2018 Patent
Compositions and methods of engineered crispr-cas9 systems using split-nexus cas9-associated polynucleotides Jul 31, 2017 May 15, 2018 Patent
Compositions and methods of engineered crispr-cas9 systems using split-nexus cas9-associated polynucleotides Jul 31, 2017 May 15, 2018 Patent
Methods for increasing cas9-mediated engineering efficiency Aug 26, 2015 May 15, 2018 Patent
Cells comprising engineered nucleic-acid targeting nucleic acids Oct 18, 2017 May 01, 2018 Patent
See all 35 patents